Admission Date:  [**2142-7-27**]              Discharge Date:   [**2142-8-28**]

Date of Birth:  [**2084-1-25**]             Sex:   M

Service: SURGERY

Allergies:
Heparin Agents

Attending:[**First Name3 (LF) 2777**]
Chief Complaint:
Left lower extemity ischemia, transfered from OSH

Major Surgical or Invasive Procedure:
[**2142-8-20**]: Left AKA
[**2142-8-2**]: Left guillotine amp
[**2142-7-30**]: LLE angio, thrombectomy of vein graft and tibial
vessles, patch angioplasty of proximal vein graft
[**2142-7-28**]: LLE angio, thrombectomy via graft and BKpop, Left
fem-BKpop with RT GSV, fasciotomy x4


History of Present Illness:
This is a 58 year old gentleman who is 5 years status post left
femoral above knee popliteal with PTFE. The day prior to
admission he experienced acute onset
of left calf and foot pain and coolness consistent with
thrombosed fem-[**Doctor Last Name **] graft on that side. Evaluated at OSH and
transfered to [**Hospital1 18**]/[**Doctor Last Name **] for continued care.

Past Medical History:
DM 2, HTN, COPD, ETOH abuse, heavy smoker
L [**Doctor Last Name 69803**] PTFE graft


Social History:
Lives at home with family.
Daily ETOH
1-2ppd Smoking history

Family History:
n/c

Physical Exam:
Admission H&P
PE: 96.9, 103, 142/82, 20 94%RA
General: NAD, pleasant, A&O X3
cards: RRR
Lungs: CTA
Abd: soft, ND, +BS
B/L palp fem
LLE cool below knee. dop [**Doctor Last Name **], -DP/PT
[**Name (NI) **] palp [**Doctor Last Name **], DP -PT

Pertinent Results:
[**2142-8-26**] WBC-7.7 RBC-3.36* Hgb-9.8* Hct-28.6* MCV-85 MCH-29.1
MCHC-34.2 RDW-14.5 Plt Ct-483*
[**2142-8-28**] PT-38.3* PTT-32.8 INR(PT)-4.3*
[**2142-8-26**] Glucose-102 UreaN-11 Creat-0.5 Na-135 K-3.6 Cl-95*
HCO3-30 AnGap-14
[**2142-8-26**] Calcium-8.7 Phos-4.3 Mg-1.9

[**2142-8-14**] 5:36 pm SWAB      LEFT BKA STUMP.

                            **FINAL REPORT [**2142-8-18**]**

   GRAM STAIN (Final [**2142-8-14**]):
      2+   (1-5 per 1000X FIELD):   POLYMORPHONUCLEAR
LEUKOCYTES.
      2+   (1-5 per 1000X FIELD):   GRAM POSITIVE COCCI.
                                    IN PAIRS.

   WOUND CULTURE (Final [**2142-8-17**]):
      ENTEROCOCCUS SP..    MODERATE GROWTH.
      ACINETOBACTER BAUMANNII.    SPARSE GROWTH.
         "Note, for Amp/sulbactam, higher-than-standard dosing
needs to be
         used, since therapeutic efficacy relies on intrinsic
activity of
         the sulbactam component".

                              SENSITIVITIES: MIC expressed in
MCG/ML

_________________________________________________________
                             ENTEROCOCCUS SP.
                             |          ACINETOBACTER BAUMANNII
                             |          |
AMPICILLIN------------   <=2 S
AMPICILLIN/SULBACTAM--             =>32 R
CEFEPIME--------------               32 R
CEFTAZIDIME-----------             =>64 R
CIPROFLOXACIN---------              =>4 R
GENTAMICIN------------                2 S
IMIPENEM--------------                8 I
LEVOFLOXACIN----------                4 I
LINEZOLID-------------     2 S
PENICILLIN------------     8 S
TOBRAMYCIN------------              <=1 S
TRIMETHOPRIM/SULFA----              <=1 S
VANCOMYCIN------------  =>32 R

   ANAEROBIC CULTURE (Final [**2142-8-18**]):    NO ANAEROBES ISOLATED

Brief Hospital Course:
[**2142-7-28**] Transferred from OSH with cold, ischemic left leg and
taken urgently to OR. UnderwentLeft lower extremity angiography,
mechanical thrombectomy of left femoral popliteal PTFE graft.
Thrombectomy of below knee popliteal anterior tibialis and
peroneal arteries and posterior tibialis arteries, right greater
saphenous vein harvest, left femoral to below knee popliteal
bypass graft with right greater saphenous vein, angioscopy and
valve lysis and fasciotomy x4. Surgery without complications and
was extubated in OR.
In [**Name (NI) 13042**], pt with symptoms of DTs. CIWA initiated and he received
Haldol and Ativan with effect. Transferred to VICU. Heparin gtt
and ABX continued. Patient continued to have tremors/DTs.
[**2142-7-30**]: Postop he was found to have a cooler foot and loss of
Doppler signal. The patient had already been systemically
heparinized so was taken urgently back to the operating room and
underwent thrombectomy and revision of left common femoral to
below- knee popliteal artery bypass graft with vein patch
angioplasty. At the time of re-exploration, he was suspected of
having HIT and was started on argatroban. HIT specimen positive.
Due to witnessed DT's preop, postop he remained intubated for
airway protection. While intubated, received tube feeds.
Transfused 1uPRBCs
[**8-2**] to OR for L guillotine BKA. Continue Vanco/Levo/Flagyl ABX.
 NS w-D dressings to BKA open stump. Transfused 2uPRBCs.
Remained intubated for airway protection due to ETOH withdrawal
until [**2142-8-7**].
[**2142-8-7**] Extubated
[**2142-8-8**] Speech and swallow evaluation for oral and pharyngeal
dysphagia following extubation.
[**2142-8-10**] Transferred from SICU to VICU.
[**2142-8-14**] Due to extensive necrosis of the patient's left BKA
stump, taken to OR for debridement .Surgery without
complication. Extubated and transferred to [**Month/Day/Year 13042**].
Pain controlled with Morphine, fentanyl patch. Transfused,
Electrolytes repleted.
[**2142-8-20**] Underwent Left above-the-knee amputation for infected
open BKA. Surgery without complication. Extubated and
transferred to [**Month/Day/Year 13042**].
[**Date range (3) 69804**] Surgical dressing changed. VSS. Tolerating po and
urinating qs. Antibiotics changed to Linezolid, Vanco d'ced
(VRE). B/L palpable femoral pulses. Amputation site healing.
Coumadin started. Continued Argatroban gtt. Daily coags.
Physical therapy initiated. Rehab screened.
Stable for transfer to acute rehab when bed available and INR
therapeutic.
[**2142-8-27**] Argatroban discontinued
[**2142-8-28**] INR 4.3. LT AKA stump c/d/i. VSS. Afebrile. Antibiotics
discontinued. B/L fem palpable. RT PT dopplerable. Continue
other current medications including Coumadin 5mg daily (adjust
to keep INR 2.0-3.0)


Discharge Medications:
1. Aspirin 325 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
2. Simvastatin 10 mg Tablet Sig: One (1) Tablet PO DAILY
(Daily).
3. Albuterol 90 mcg/Actuation Aerosol Sig: 1-2 Puffs Inhalation
Q4H (every 4 hours).
4. Ipratropium Bromide 17 mcg/Actuation Aerosol Sig: Two (2)
Puff Inhalation Q6H (every 6 hours).
5. Acetaminophen 160 mg/5 mL Solution Sig: One (1)  PO Q4-6H
(every 4 to 6 hours) as needed.
6. Famotidine 20 mg Tablet Sig: One (1) Tablet PO Q12H (every 12
hours).
7. Quetiapine 25 mg Tablet Sig: One (1) Tablet PO BID (2 times a
day).
8. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2
times a day).
9. Fentanyl 50 mcg/hr Patch 72HR Sig: One (1) Patch 72HR
Transdermal Q72H (every 72 hours).
10. Gabapentin 100 mg Capsule Sig: Two (2) Capsule PO q8hr ().
11. Metoprolol Tartrate 50 mg Tablet Sig: One (1) Tablet PO BID
(2 times a day).
12. Furosemide 40 mg Tablet Sig: One (1) Tablet PO BID (2 times
a day).
13. Warfarin 5 mg Tablet Sig: One (1) Tablet PO HS (at bedtime):
Adjust to maintain INR of 2.0-3.0.
14. Oxycodone-Acetaminophen 5-325 mg Tablet Sig: 1-2 Tablets PO
Q4-6H (every 4 to 6 hours) as needed for pain.
15. Senna 8.6 mg Tablet Sig: 1-2 Tablets PO BID (2 times a day)
as needed.
16. Bisacodyl 5 mg Tablet, Delayed Release (E.C.) Sig: Two (2)
Tablet, Delayed Release (E.C.) PO DAILY (Daily) as needed.
17. Insulin
Breakfast and Bedtime- NPH 10  Units
Fingerstick before meals and bed-cover with regulsr sliding
scale

Insulin SC Sliding Scale
Breakfast Lunch Dinner Bedtime Q0H

Glucose Insulin Dose Insulin Dose Insulin Dose Insulin Dose
Insulin Dose
0-60  mg/dL [**1-15**] amp D50
61-120  mg/dL 0 Units
121-140 mg/dL 3 Units
141-160 mg/dL 6 Units
161-180 mg/dL 9 Units
181-200 mg/dL 12 Units
201-220 mg/dL 15 Units
221-240 mg/dL 18 Units
241-260 mg/dL 21 Units
261-280 mg/dL 24 Units
281-300 mg/dL 27 Units
301-320 mg/dL 30 Units
Notify M.D.


Discharge Disposition:
Extended Care

Facility:
[**Hospital3 7665**]

Discharge Diagnosis:
Peripheral arterial disease
DM 2, HTN, COPD, ETOH, heavy smoker
history of L [**Doctor Last Name 69803**] PTFE graft


Dischar